Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-myeloablative Conditioning”

399 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 399 results

Testing effectiveness (Phase 2)Study completedNCT00863148
What this trial is testing

Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
MDSAMLALL+1 more
Nantes University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00797758
What this trial is testing

Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris 76
Testing effectiveness (Phase 2)Study completedNCT01050855
What this trial is testing

Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders

Who this might be right for
Non Malignant DiseasesImmunodeficienciesHemoglobinopathies
Children's Hospital of Philadelphia 56
Testing effectiveness (Phase 2)Study completedNCT01643668
What this trial is testing

Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Massachusetts General Hospital 34
Testing effectiveness (Phase 2)Ended earlyNCT00318110
What this trial is testing

Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Center for International Blood and Marrow Transplant Research 4
Testing effectiveness (Phase 2)Study completedNCT00802113
What this trial is testing

Autologous and Allogeneic Transplant for Relapsed Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaHodgkins Disease
Columbia University 30
Large-scale testing (Phase 3)WithdrawnNCT00226512
What this trial is testing

To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Hadassah Medical Organization 203
Testing effectiveness (Phase 2)Study completedNCT01251575
What this trial is testing

Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Adult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more
Fred Hutchinson Cancer Center 77
Testing effectiveness (Phase 2)Study completedNCT00607854
What this trial is testing

Safety of Ibritumomab Tiuxetan (Zevalin®) in Combination With a Fludarabine-based Reduced Intensity Conditioning (RIC) Regimen (ZEVALLO 2007)

Who this might be right for
Diffuse Large B-Cell LymphomaMantle Cell Lymphoma
University Hospital, Bordeaux 31
Testing effectiveness (Phase 2)Looking for participantsNCT01804634
What this trial is testing

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Who this might be right for
Refractory and/or Relapsed Metastatic Solid Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Testing effectiveness (Phase 2)Ended earlyNCT00001880
What this trial is testing

Stem Cell Transplantation for Metastatic Solid Tumors

Who this might be right for
Neoplasm Metastasis
National Heart, Lung, and Blood Institute (NHLBI) 42
Testing effectiveness (Phase 2)Looking for participantsNCT03128996
What this trial is testing

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Who this might be right for
Severe Sickle Cell DiseaseBone Marrow Failure SyndromesMetabolic Disorders+3 more
Washington University School of Medicine 29
Testing effectiveness (Phase 2)Ended earlyNCT02207985
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Karolinska Institutet 10
Large-scale testing (Phase 3)Study completedNCT03959241
What this trial is testing

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

Who this might be right for
Acute LeukemiaChronic Myelogenous Leukemia (CML)Myelodysplasia+1 more
Medical College of Wisconsin 431
Testing effectiveness (Phase 2)Study completedNCT00910650
What this trial is testing

Study of Gene Modified Immune Cells in Patients With Advanced Melanoma

Who this might be right for
Metastatic Melanoma
Jonsson Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Testing effectiveness (Phase 2)Study completedNCT02581007
What this trial is testing

Reduced Intensity Conditioning Transplant Using Haploidentical Donors

Who this might be right for
Chronic Myelogenous LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndrome+7 more
Northside Hospital, Inc. 25
Not applicableStudy completedNCT00997529
What this trial is testing

Mini Allo Stem Cell Transplantation for the Treatment of Solid Tumors

Who this might be right for
Metastatic Solid Tumor
Beth Israel Deaconess Medical Center 14
Testing effectiveness (Phase 2)UnknownNCT02776202
What this trial is testing

HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen

Who this might be right for
Sickle Cell Disease
National Guard Health Affairs 15
Testing effectiveness (Phase 2)WithdrawnNCT00242931
What this trial is testing

Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute
Next Page